EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Fasting and diurnal blood ketonemia and glycemia responses to a six-week, energy-controlled ketogenic diet, supplemented with racemic R/S-BHB salts

Alex Buga, Madison L Kackley, Christopher D Crabtree, Teryn N Bedell, Bradley T Robinson, Justen T Stoner, Drew D Decker, Parker N Hyde, Rich A LaFountain, Milene L Brownlow, Annalouise O'Connor, Deepa Krishnan und 3 weitere

Clinical Nutrition ESPEN · 2023

DOI: 10.1016/j.clnesp.2023.01.030 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition ESPEN, 2023. Verfasst von Alex Buga und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Sciences, The Ohio State University, Columbus, OH 43210, USA. Hauptthemen laut MEDLINE: Diet, Ketogenic, Ketosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Melville Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Single doses of exogenous ketone salts (KS) transiently increase circulating beta-hydroxybutyrate (BHB) (∼1 mM; 1-2 h) regardless of starting levels of ketosis; however, no studies have explored how sustained use of KS influences measures of ketonemia and glycemia. OBJECTIVES: To determine the response to a hypocaloric, well-formulated ketogenic diet (KD), with and without the inclusion of two daily racemic KS doses (6 g R-BHB + 6 g S-BHB per serving) on 1) daily fasting capillary R-BHB and glucose (R-BHB/GLUfast), 2) bi-weekly 13 h diurnal BHB and glucose (R-BHB/GLUdiur), 3) three-hours post-KS ingestion kinetics (R-BHBKS), and 4) bi-weekly fasting plasma enantiomer-specific BHB (R/S-BHBplasma). METHODS: Non-diabetic adults with overweight and obesity were randomized to receive a precisely measured hypocaloric KD (∼75 %en of maintenance) for six weeks, supplemented twice-daily with KS or placebo (PL). A non-randomized comparison group was provided an isonitrogenous/isoenergetic low-fat diet (LFD). All meals were provided to subjects. Capillary blood was collected daily to measure R-BHB/GLUfast and hourly for R-BHB/GLUdiur. Plasma was collected to measure R/S-BHBplasma, insulin, fasting glucose, and insulin resistance (HOMA-IR). Total AUC was calculated using the trapezoidal method. RESULTS: Mean R-BHBfast increased significantly during KD + PL (1.0 mM BHB), an effect enhanced 26% during KD + KS. GLUfast AUC was -6% lower during KD + KS versus LFD. Mean R-BHBdiur increased 40% in KD + KS versus KD + PL, whereas GLUdiur decreased 13% during both KDs versus LFD. R-BHBKS peaked (Δ: ∼1 mM) 1 h after the morning KS dose, but not following the afternoon dose. Both R/S-BHBplasma increased during KD independent of KS inclusion. R-BHBplasma was 50-times greater compared to S-BHBplasma, and the KS augmented S-BHBplasma 50% more than PL. Fasting insulin and HOMA-IR decreased after 14 days independent of diet. CONCLUSIONS: A hypocaloric KD was effective at reducing diurnal glucose compared to a LFD independent of weight loss, but twice-daily racemic KS ingestion during KD augmented ketonemia, both as R- and S-BHB, and decreased mean fasting glucose beyond a KD alone. The hypoglycemic effects of KD in combination with exogenous ketones merit further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, KetogenicKetosisAdultHumans3-Hydroxybutyric AcidSaltsKetone BodiesKetonesGlucoseInsulinFasting

Stichwörter der Autor:innen

Beta-hydroxybutyrateGlucoseKetogenic dietKetone saltsLow-fat dietWeight loss

Substanzen

3-Hydroxybutyric AcidSaltsKetone BodiesKetonesGlucoseInsulin

Autor:innen und Institutionen

  • Department of Human Sciences, The Ohio State University, Columbus, OH 43210, USA.
  • Department of Kinesiology, University of Northern Georgia, Dahlonega, GA 30597, USA.
  • Big Sky Health, Big Sky, MT 59716, USA.
  • National Institute of Environmental Health Sciences, Durham, NC 27709, USA.
  • Danone, Inc., Broomfield, CO 80021, USA.
  • College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.

Förderung

  • Melville Charitable Trust

Zitieren

APA

Buga, A., Kackley, M. L., Crabtree, C. D., Bedell, T. N., Robinson, B. T., Stoner, J. T., Decker, D. D., Hyde, P. N., LaFountain, R. A., Brownlow, M. L., O'Connor, A., Krishnan, D., McElroy, C. A., Kraemer, W. J., & Volek, J. S. (2023). Fasting and diurnal blood ketonemia and glycemia responses to a six-week, energy-controlled ketogenic diet, supplemented with racemic R/S-BHB salts. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2023.01.030

Vancouver

Buga A, Kackley ML, Crabtree CD, Bedell TN, Robinson BT, Stoner JT, et al. Fasting and diurnal blood ketonemia and glycemia responses to a six-week, energy-controlled ketogenic diet, supplemented with racemic R/S-BHB salts. Clinical Nutrition ESPEN. 2023. doi:10.1016/j.clnesp.2023.01.030

BibTeX
@article{Buga2023,
  author = {Buga, Alex and Kackley, Madison L and Crabtree, Christopher D and Bedell, Teryn N and Robinson, Bradley T and Stoner, Justen T and Decker, Drew D and Hyde, Parker N and LaFountain, Rich A and Brownlow, Milene L and O'Connor, Annalouise and Krishnan, Deepa and McElroy, Craig A and Kraemer, William J and Volek, Jeff S},
  title = {Fasting and diurnal blood ketonemia and glycemia responses to a six-week, energy-controlled ketogenic diet, supplemented with racemic R/S-BHB salts},
  journal = {Clinical Nutrition ESPEN},
  year = {2023},
  doi = {10.1016/j.clnesp.2023.01.030}
}
Kostenlos starten →